We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Consensus and Guidelines · November 09, 2021

Guidelines on the Use of Anticoagulation for Thromboprophylaxis in COVID-19

Blood advances

 

Additional Info

Blood advances
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Blood Adv 2021 Oct 26;5(20)3951-3959, A Cuker, EK Tseng, R Nieuwlaat, P Angchaisuksiri, C Blair, K Dane, J Davila, MT DeSancho, D Diuguid, DO Griffin, SR Kahn, FA Klok, AI Lee, I Neumann, A Pai, M Righini, KM Sanfilippo, D Siegal, M Skara, DR Terrell, K Touri, EA Akl, I Bou Akl, A Bognanni, M Boulos, R Brignardello-Petersen, R Charide, M Chan, K Dearness, AJ Darzi, P Kolb, LE Colunga-Lozano, R Mansour, GP Morgano, RZ Morsi, G Muti-Schünemann, A Noori, BA Philip, T Piggott, Y Qiu, Y Roldan, F Schünemann, A Stevens, K Solo, W Wiercioch, RA Mustafa, HJ Schünemann

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading